Tumour Grade, Proliferation, Apoptosis, Microvessel Density, p53, and bcl-2 in Prostate Cancers: Differences Between Tumours Located in the Transition Zone and in the Peripheral Zone
- 1 January 2002
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 41 (1), 40-46
- https://doi.org/10.1016/s0302-2838(01)00021-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocalityProstate Cancer and Prostatic Diseases, 1999
- LOCALLY RECURRENT PROSTATE TUMORS FOLLOWING EITHER RADIATION THERAPY OR RADICAL PROSTATECTOMY HAVE CHANGES IN KI-67 LABELING INDEX, P53 AND BCL-2 IMMUNOREACTIVITYJournal of Urology, 1998
- NUMERICAL CHROMOSOMAL ABERRATIONS IN TRANSITION-ZONE CARCINOMAS OF THE PROSTATEJournal of Urology, 1997
- Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy.Journal of Clinical Pathology, 1997
- Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate CancerJournal of Urology, 1996
- Ki-67 expression in early prostate cancer and associated pathological lesions.Journal of Clinical Pathology, 1996
- Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical ProstatectomyJournal of Urology, 1996
- Zonal Distribution of Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1988
- Normal Histology of the ProstateThe American Journal of Surgical Pathology, 1988
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981